TriSalus Life Sciences Financial Overview
TriSalus Life Sciences's market cap is currently $352.25M. The company's EPS TTM is $-0.96; its P/E ratio is ―; TriSalus Life Sciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
